The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Pound Falls On Brexit Impasse, Stocks End Higher

Fri, 21st Sep 2018 17:21

LONDON (Alliance News) - Stocks ended the week on a high as UK Prime Minster Theresa May's speech on Brexit caused the pound to tumble Friday afternoon, in turn, driving the FTSE 100 upwards."We are witnessing familiar Brexit reaction in market terms, as a cliff-dive for the pound is matched by a leap higher for the FTSE 100 as the prime minister talks tough after her humiliation in Salzburg," said Chris Beauchamp, chief market analyst at IG. Beauchamp added: "Many Britons watching her will be able to sympathise, since no one likes being made to look foolish, but the hardening of rhetoric has just made a 'no deal' more likely, and this is why we're seeing sterling so heavily sold. Given the steady losses in GBP/USD since April, today's move could mark the resumption of the downtrend." "And for once the FTSE 100 is the star performer among the indices, although given that we are seeing bullish momentum fade slightly after a very healthy week this bounce may be short-lived."The pound was quoted at USD1.307 at the London equities close Friday, sharply lower from USD1.3187 at midday and USD1.3265 at the close on Thursday. The FTSE 100 index finished higher to close 1.7% up, or 122.91 points, at 7,490.23. The FTSE 250 ended up 0.2%, or 39.10 points, at 20,590.36, and the AIM All-Share closed 0.5% higher, or 5.00 points, at 1,099.89.The Cboe UK 100 ended up 1.5% at 12,684.80, the Cboe 250 closed up 0.1% at 18,682.27, and the Cboe Small Companies ended 0.2% higher at 12,218.21.Theresa May called on the EU to come forward with fresh proposals on Northern Ireland and trade, warning that without a move from Brussels it will not be possible to make further progress in Brexit talks.Speaking in 10 Downing Street - a day after the humiliating rejection of her Brexit plans at the EU summit in Salzburg - the prime minister said that Brexit negotiations had reached an "impasse".But she dismissed EU suggestions that the onus is on Britain to shift its stance, insisting that the ball is now in the EU's court.May said she was ready to come forward with new ideas on unblocking the disagreement over future arrangements at the Irish border.But, in apparent reference to European Council President Donald Tusk's assertion that her Chequers plan "will not work", she said "At this late stage in the negotiations, it is not acceptable to simply reject the other side's proposals without a detailed explanation and new proposals.""So we now need to hear from the EU what the real issues are and what their proposals are so we can discuss them. Until we do, we can't make progress," May said.May added: "No-one wants a good deal more than me, but the EU should be clear - I will not overturn the result of the referendum, nor will I break up my country.""We need serious engagement on resolving the two big problems in the negotiations and we stand ready," May said.A ruling from Scotland's highest court will see the European Court be asked if the UK can unilaterally revoke its Article 50 request to leave the EU.In what campaigners described as a "case that could decide the fate of the nation", the Court of Session in Edinburgh announced it would refer the question on to the Court of Justice of the EU.As a result of the "urgency of the issue", with the UK due to leave the EU on March 29, it said the request was being expedited procedure.The decision from Lord Carloway, Scotland's most senior judge and Lord President of the Court of Session, overturns a ruling in June when it was said the question being asked was "hypothetical" and the conditions for a reference had not been met.But Lord Carloway said it was "clear" MPs at Westminster would be required to vote on any Brexit deal agreed by the EU and the UK Government.He stated: "It seems neither academic nor premature to ask whether it is legally competent to revoke the notification and thus to remain in the EU. The matter is uncertain in that it is the subject of a dispute; as this litigation perhaps demonstrates."The answer will have the effect of clarifying the options open to MPs in the lead up to what is now an inevitable vote."Brent oil was quoted lower at USD78.66 a barrel at the equities close from USD78.86 at the same time the prior day. Gold was quoted at USD1,196.80 an ounce at the London equities close against USD1,204.01 on Thursday.On the London Stock Exchange, blue chip miners were big risers as the US China trade war appeared to slow down during the week.Antofagasta closed up 4.4%, Glencore finished 4.7% higher, BHP Billiton closed up 3.7%, Anglo American closed up 3.9% and Rio Tino closed up 2.7%.Royal Dutch Shell A shares gained 2.2% after Bloomberg News reported the oil giant is in talks to sell its interest in a Gulf of Mexico oilfield to Focus Oil Co, which could fetch up to USD1.3 billion. Shell's B shares were up 2.5%.GlaxoSmithKline closed up 3.1% after it received a positive opinion on broadening the use of its Trelegy Ellipta inhaler in patients with chronic obstructive pulmonary disease.This opinion comes from the European Medicines Agency's Committee for Medicinal Products for Human Use, and would see the labelling for the drug modified to encompass a broader group of patients with moderate to severe forms of the disease.At the other end of the FTSE 100, food firm Just Eat finished as the worst performer, down 4.8%.Brokers said the acquisition talks between Uber and Roofoods, better known as Deliveroo, represented a potential threat to Just Eat.Peel Hunt stated the deal could be "a shift in the paradigm of the cooked food delivery market in the UK", and could particularly place a lot of pressure on Just Eat.Not far behind was Smiths Group, finishing 4.4% lower.The engineering group reported a decline in pretax profit for the year to the end of July to GBP435 million, from GBP601 million reported the year earlier.Revenue slipped by 2.0% to GBP3.21 billion from GBP3.28 billion.Revenue suffered from unfavourable currency translation rates, with underlying revenue, which excludes the effects of foreign exchange, acquisitions and supplemental sales for divested businesses, up 2% year-on-year.In the FTSE 250, SIG closed up 1.1%, after being down 1.7% at midday. The building products company posted pretax profit of GBP19.9 million for the six months to the end of June, compared to a GBP15.8 million loss a year prior.The absence of a GBP50.2 million loss from the sale and closure of non-core businesses and other items related to the disposal of property in the first half of 2017 explained the increase.However, revenue slipped to GBP1.38 billion from GBP1.43 billion a year ago on difficult UK trading due to poor weather and political uncertainty.In economic news, the UK budget deficit increased in August on higher expenditure amid subdued income growth, data from the Office for National Statistics showed.Public sector net borrowing, excluding public sector banks, rose by GBP2.4 billion from last year to GBP6.8 billion in August. Borrowing was expected to fall to GBP3.4 billion.This was the largest August borrowing for two years and the first annual increase for August in three years.At the end of August, public sector net debt excluding public sector banks totaled GBP1.78 trillion or 84.3% of gross domestic product. Debt increased by GBP15.9 billion from a year ago.In Paris the CAC 40 was up 0.8%, while the DAX 30 in Frankfurt was up 0.9%. The euro stood at USD1.1744 at the European equities close, against USD1.1760 the prior day.The Eurozone private sector grew at the second-weakest pace since late-2016 as manufacturing growth was subdued by stagnating export orders, flash survey data from IHS Markit showed.The composite output index fell to 54.2 in September, while the score was forecast to remain unchanged at 54.5. Although the reading was well above the 50.0 no-change level, it was the lowest since November 2016 with the exception of last May.The slowdown was driven by weaker growth in the manufacturing sector as export orders failed to grow for the first time since June 2013. Meanwhile, the service sector output growth picked up momentum for a second successive month to reach a three-month high.The manufacturing Purchasing Managers' Index dropped to a 24-month low of 53.3 from 54.6 a month ago. The score was expected to fall slightly to 54.5.Meanwhile, the services PMI rose to a three-month high of 54.7 in September. The indicator was expected to remain at 54.4.Chris Williamson, chief business economist at IHS Markit, said, "A near stagnation of exports contributed to one of the worst months for the Eurozone economy for almost two years.""Trade wars, Brexit, waning global demand, notably in the auto industry, growing risk aversion, destocking and rising political uncertainty both within the Eurozone and further afield all fueled the slowdown in business activity," Williamson added.Stocks in New York were mixed at the London equities close. The DJIA was up 0.3%, the S&P 500 index up 0.2% and the Nasdaq Composite down 0.2%.China has warned the US will "bear the consequences" if it does not withdraw punishing financial sanctions it imposed on a key Chinese military organization for buying Russian fighter jets and missiles.The Chinese Foreign Ministry said the sanctions, which were imposed over Beijing's purchase of Russian military jets and surface-to-air missiles, "seriously damaged" relations between US and China and their militaries."We strongly urge the US to immediately correct the mistakes and revoke the so-called sanctions; otherwise the US must bear the consequences," ministry spokesman Geng Shuang said.Elsewhere, S&P Global Ratings affirmed the sovereign ratings of China with 'stable' outlook.The 'A+' credit rating reflects S&P's assessment of the government's reform agenda, growth prospects, and strong external metrics.The economic calendar on Monday has UK CBI Industry trends survey at 0930 BST. The Shanghai, Tokyo and Johannesburg stock exchanges are closed.The UK corporate calendar has full year results from River & Mercantile and half year results from XLMedia, Gamma Aviation with a trading statement from Pennon Group.

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.